ethyl 2-formyl-3-(6-methoxy-pyridin-3-yl)propionate | 72716-98-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: ethyl 2-formyl-3-(6-methoxy-pyridin-3-yl)propionate
• 英文别名: ethyl 2-formyl-3-(6-methoxy-3-pyridyl)propionate；ethyl 2-formyl-3-(6-methoxypyridin-3-yl)propanoate
• CAS: 72716-98-4
• 化学式: C₁₂H₁₅NO₄
• 分子量: 237.255
• InChiKey: MHHUXKYMQGCHOW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  65.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ethyl 2-formyl-3-(6-methoxy-pyridin-3-yl)propionate 在 sodium methylate 作用下， 以 甲醇 、 乙醇 为溶剂， 反应 42.0h， 生成 2-[2-(5-dimethylaminomethyl-furan-2-ylmethylthio)ethylamino]-5-(6-methoxy-pyridin-3-ylmethyl)-4-pyrimidone
  参考文献：
  名称：

  Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds

  摘要：

  The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.

  DOI：

  10.1016/0223-5234(93)90091-r
• 作为产物：
  描述：

  6-甲氧基烟腈 在 palladium on activated charcoal 、 镍 哌啶 、 吡啶 、 盐酸 、 聚合甲醛 、 氢气 、 盐酸氨基脲 、 sodium acetate 、 sodium hydride 作用下， 以 乙二醇二甲醚 、 乙醇 为溶剂， 反应 20.25h， 生成 ethyl 2-formyl-3-(6-methoxy-pyridin-3-yl)propionate
  参考文献：
  名称：

  Isocytosine H2-receptor histamine antagonists. IV. The synthesis and biological activity of donetidine (SK&F 93574) and related compounds

  摘要：

  The synthesis and biological activity of some novel 2-amino-4-pyrimidone derivatives is described. Side-chains associated with H-2-antagonist activity am attached through the 2-amino group, whilst a range of 2-hydroxypyridine containing moieties are substituted at the 5-position of the pyrimidone ring. Good H-2-receptor histamine antagonist activity is observed with all the series and the majority of the compounds are selective for the H-2-receptor. High aqueous solubility and iv potency coupled with an extended duration of biological activity in animal models led to compound 16c, 2-[2-(5-dimethylaminomethyl-2-furanylmethyl-thio)ethylamino]-5-(2-hydroxypyrid-4-ylmethyl)-4-pyrimidone (donetidine, SK&F 93574) being selected for clinical investigation as a potential parenterally administered therapeutic agent.

  DOI：

  10.1016/0223-5234(93)90091-r

文献信息

• Intermediates in the process for making histamine antagonists
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04227000A1

  公开（公告）日：1980-10-07

  A process for making substituted 2-aminopyrimidones which are histamine H.sub.2 - antagonists which comprises reacting a 2-nitroaminopyrimidone with a heteroarylalkylamine, heteroarylalkylthioalkylamine, or heteroarylalkoxyalkylamine. One particular compound which can be made by this process is 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-[5-(1,3-benzodioxolyl) methyl]-4-pyrimidone. Also claimed are 2-nitroaminopyrimidone intermediates for use in this process. One specific intermediate is 2-nitroamino-5-[5-(1,3-benzodioxolyl)methyl]-4-pyrimidone.

  一种制备取代2-氨基嘧啶酮的方法，这些化合物是组胺H.sub.2-拮抗剂，包括将2-硝基氨基嘧啶酮与杂环烷基胺、杂环烷基硫代烷基胺或杂环烷基氧代烷基胺反应。通过这种方法可以制备一种特定化合物，即2-[2-(5-甲基-4-咪唑基甲硫基)乙基氨基]-5-[5-(1,3-苯并二氧杂环己基)甲基]-4-嘧啶酮。此外，还声明了用于该方法的2-硝基氨基嘧啶酮中间体。其中一个特定的中间体是2-硝基氨基-5-[5-(1,3-苯并二氧杂环己基)甲基]-4-嘧啶酮。
• 5-(Hydroxypyridylalkyl)-4-pyrimidones
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04255428A1

  公开（公告）日：1981-03-10

  The compounds are substituted 2-amino-4-pyrimidones with a 5-(hydroxypyridylalkyl) substituent which are histamine H.sub.2 -antagonists. Two specific compounds are 2-[2-(3-bromo-2-pyridylmethylthio)ethylamino]-5-(2-hydroxy-4-pyridylmethyl )-4-pyrimidone and 2-[4-(3-methoxy-2-pyridyl)butylamino]-5-(2-hydroxy-4-pyridylmethyl)-4-pyri midone.

  这些化合物是具有5-(羟基吡啶基)取代基的2-氨基-4-嘧啶酮，是组胺H.sub.2-拮抗剂。两种特定的化合物是2-[2-(3-溴-2-吡啶甲硫基)乙基氨基]-5-(2-羟基-4-吡啶甲基)-4-嘧啶酮和2-[4-(3-甲氧基-2-吡啶基)丁基氨基]-5-(2-羟基-4-吡啶甲基)-4-嘧啶酮。
• Pyrimidine compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04234588A1

  公开（公告）日：1980-11-18

  The compounds are substituted pyrimidine compounds which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(5-dimethylaminomethyl)-2-furylmethylthio)ethylamino]-5-(3-pyridylmet hyl)-4-pyrimidone.

  这些化合物是被取代的嘧啶化合物，它们是组胺H.sub.2-拮抗剂。本发明的一种特定化合物是2-[2-(5-二甲胺甲基)-2-呋喃甲硫基)乙基氨基]-5-(3-吡啶甲基)-4-嘧啶酮。
• Process and nitroaminopyrimidone intermediates for histamine H.sub.2
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04523015A1

  公开（公告）日：1985-06-11

  A process for making substituted 2-aminopyrimidones which are histamine H.sub.2 -antagonists which comprises reacting a 2-nitroaminopyrimidone with a heteroarylalkylamine, heteroarylalkylthioalkylamine, or heteroarylalkoxyalkylamine. One particular compound which can be made by this process is 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-[5-(1,3-benzodioxyolyl )methyl]-4-pyrimidone. Also claimed are 2-nitroaminopyrimidone intermediates for use in this process. One specific intermediate is 2-nitroamino-5-[5-(1,3-benzodioxyolyl)methyl]-4-pyrimidone.

  一种制备取代的2-氨基嘧啶酮的方法，这些化合物是组胺H.sub.2-拮抗剂，包括将2-硝基氨基嘧啶酮与杂环烷基胺，杂环烷基硫代烷基胺或杂环烷基氧代烷基胺反应。该方法可以制备出一种特定的化合物，即2-[2-(5-甲基-4-咪唑基甲硫基)乙基氨基]-5-[5-(1,3-苯并二氧杂环基)甲基]-4-嘧啶酮。还声明了用于该方法的2-硝基氨基嘧啶酮中间体。其中一个具体的中间体是2-硝基氨基-5-[5-(1,3-苯并二氧杂环基)甲基]-4-嘧啶酮。
• ——
  作者：

  DOI：——

  日期：——